Cargando…
Rapid Strategy for Screening by Pyrosequencing of Influenza Virus Reassortants - Candidates for Live Attenuated Vaccines
BACKGROUND: Live attenuated influenza vaccine viruses (LAIVs) can be generated by classical reassortment of gene segments between a cold adapted, temperature sensitive and attenuated Master Donor Virus (MDV) and a seasonal wild-type (wt) virus. The vaccine candidates contain hemagglutinin (HA) and n...
Autores principales: | Shcherbik, Svetlana V., Pearce, Nicholas C., Levine, Marnie L., Klimov, Alexander I., Villanueva, Julie M., Bousse, Tatiana L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960276/ https://www.ncbi.nlm.nih.gov/pubmed/24647786 http://dx.doi.org/10.1371/journal.pone.0092580 |
Ejemplares similares
-
Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses
por: Shcherbik, Svetlana, et al.
Publicado: (2015) -
Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation
por: Shcherbik, Svetlana, et al.
Publicado: (2015) -
Rapid Detection and Subtyping of Human Influenza A Viruses and Reassortants by Pyrosequencing
por: Deng, Yi-Mo, et al.
Publicado: (2011) -
Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein
por: Rekstin, Andrey, et al.
Publicado: (2017) -
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)
por: Rudenko, Larisa, et al.
Publicado: (2008)